You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selumetinib, Differentiated Thyroid Cancer , AZD6244

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Metastatic Radioiodine-Refractory

Recruiting
  • Thyroid Neoplasms
  • Anlotinib Hydrochloride Capsule
  • Beijing, Beijing, China
  • +2 more
Aug 9, 2023

Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

Active, not recruiting
  • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
  • +25 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Torrance, California
  • +6 more
Jan 12, 2023

Differentiated Thyroid Cancer, Thyroid Cancer, Nonmedullary Trial in La Roche-sur-Yon, Nantes (WGS)

Recruiting
  • Differentiated Thyroid Cancer
  • Thyroid Cancer, Nonmedullary
  • WGS
  • La Roche-sur-Yon, France
  • +1 more
Feb 25, 2022

Thyroid Disease Trial in Syracuse (SPECT)

Enrolling by invitation
  • Thyroid Disease
  • SPECT
  • Syracuse, New York
    SUNY Upstate Medical University
Aug 31, 2023

Thyroid Cancer, Intermediate Risk Trial in France (Systematic RAI-treatment, Decision of RAI-treatment guided by a

Recruiting
  • Thyroid Cancer
  • Intermediate Risk
  • Systematic RAI-treatment
  • Decision of RAI-treatment guided by a post-operative assessment
  • Angers, France
  • +26 more
Jul 26, 2022

Anaplastic Thyroid Cancer, Relapsed/Refractory Poorly Differentiated Thyroid Cancer Trial in New York, Houston (AIC100 CAR T

Recruiting
  • Anaplastic Thyroid Cancer
  • Relapsed/Refractory Poorly Differentiated Thyroid Cancer
  • AIC100 CAR T Cells
  • New York, New York
    Weill Cornell Medical College
Feb 14, 2022

Thyroid Tumor Follicular, Bone Metastases Trial in Beijing (Sr-89)

Not yet recruiting
  • Thyroid Neoplasm Follicular
  • Bone Metastases
  • Beijing, China
    Peking Union Medical College Hospital
Jul 18, 2022

Disease Burden, Genetic Heterogeneity and Tumour Evolution in

Recruiting
  • Thyroid Cancer
  • Sample collection only
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Apr 28, 2023

Differentiated Thyroid Cancer Trial in Worldwide (Vandetanib (SAR390530), Placebo)

Active, not recruiting
Has Results
  • Differentiated Thyroid Cancer
  • Vandetanib (SAR390530)
  • Placebo
  • Little Rock, Arkansas
  • +60 more
Oct 20, 2021

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

Thyroid Cancer Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (drug, radiation,

Recruiting
  • Thyroid Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Differentiated Thyroid Cancer Trial in Spain (Cabozantinib)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Oviedo, Asturias, Spain
  • +9 more
Dec 14, 2022

Thyroid Cancer Trial in Peking (Apatinib)

Completed
  • Thyroid Cancer
  • Peking, China
    Peking Union Medical College Hospital
Jan 18, 2022

DTC - Differentiated Thyroid Cancer Trial in Beijing (Anlotinib HCl)

Recruiting
  • DTC - Differentiated Thyroid Cancer
  • Anlotinib hydrochloride
  • Beijing, China
    Peking Union Medical College Hospital
Jan 18, 2022

Selenium Deficiency, Thyroid Cancer TNM Staging, Recurrence Trial in Jinan (Selenium Yeast, Placebo)

Not yet recruiting
  • Selenium Deficiency
  • +3 more
  • Selenium Yeast
  • Placebo
  • Jinan, Shandong, China
    The First affiliated hospital of Shandong First Medical Universi
Mar 11, 2022

Differentiated Thyroid Cancer Trial in United Kingdom (Total Thyroidectomy, Hemithyroidectomy)

Recruiting
  • Differentiated Thyroid Cancer
  • Total Thyroidectomy
  • Hemithyroidectomy
  • Cambridge, United Kingdom
  • +11 more
Oct 31, 2022

Differentiated Thyroid Cancer, Advanced Cancer Trial in Boston (LENVATINIB)

Recruiting
  • Differentiated Thyroid Cancer
  • Advanced Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 3, 2022

Thyroid Cancer Trial in Taipei

Active, not recruiting
  • Thyroid Cancer
    • Taipei, Taipei City, Taiwan
      National Taiwan University Hospital
    Nov 14, 2021

    Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • Locally Advanced Malignant Solid Neoplasm
    • (no location specified)
    Dec 2, 2022

    Differentiated Thyroid Cancer Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

    Recruiting
    • Differentiated Thyroid Cancer
    • Caba, Buenos Aires, Argentina
    • +41 more
    Nov 25, 2022

    Thyroid Cancer, Thyroid Cancer, Medullary, Differentiated Thyroid Cancer Trial in Tampa (Lenvatinib, Sorafenib, Cabozantinib)

    Terminated
    Has Results
    • Thyroid Cancer
    • +5 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jul 12, 2021

    Thyroid Cancer Trial in Suita (Targeted alpha therapy)

    Recruiting
    • Thyroid Cancer
    • Targeted alpha therapy
    • Suita, Japan
      Osaka University Hospital
    Mar 2, 2022

    Thyroid Cancer Trial in Beijing (Anlotinib HCl, Sodium Iodide I 131, Penpulimab)

    Recruiting
    • Thyroid Cancer
    • Anlotinib hydrochloride
    • +2 more
    • Beijing, China
      Peking Union Medical College Hospital
    Jan 18, 2022

    Radioactive Iodine-refractory Differentiated Thyroid Cancer Trial in Beijing (Camrelizumab combination with Apatinib)

    Recruiting
    • Radioactive Iodine-refractory Differentiated Thyroid Cancer
    • Camrelizumab combination with Apatinib
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jan 18, 2022

    Thyroid Cancer Metastatic Trial in France (Lenvatinib + Denosumab)

    Recruiting
    • Thyroid Cancer Metastatic
    • Lenvatinib + Denosumab
    • Angers, France
    • +13 more
    Mar 14, 2022